About Us

Alan Schneyer, Ph.D., CEO (Co-founder)

Alan Schneyer, CEO of Fairbanks PharmaceuticalsDr Schneyer passed away in November, 2020.

Following his undergraduate degree from the University of Pennsylvania and his doctoral degree from the University of Miami, Dr. Schneyer was awarded an NIH Postdoctoral Fellowship at Albany Medical College where he was trained in biochemical endocrinology. In 1987 he was recruited to the Massachusetts General Hospital where he ran an NIH-funded laboratory for 20 years.  In 2007, he moved to the Pioneer Valley Life Science Institute to pursue his discovery that the protein Follistatin Like-3 (FSTL3) was involved with regulating insulin-producing pancreatic beta cells.  In 2012, he joined the faculty of the Veterinary and Animal Science Department at University of Massachusetts-Amherst .  Over the years, funding for his work was provided by the National Institutes of Health and the Juvenile Diabetes Research Foundation.  Dr. Schneyer is the Co-founder of Fairbanks Pharmaceuticals and directed all research programs.

Elissa Brown, MS, Chief Operating Officer (Co-founder)

Ms Brown is Co-founder of Fairbanks Pharmaceuticals.  She has been involved with business development and consulting for over 30 years and provides long-range planning for the Company.  Ms. Brown has an undergraduate degree from Hamilton College and a master’s degree from Northwestern University.